arrow
Y

Yacine Barèche

institut jules bordet
H指数:19
被引数:2,308

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab

免疫治疗生物标志物的漫长而曲折的道路: 对使用pembrolizumab治疗的三阴性乳腺癌患者样本的回顾性分析

2024-05-010
OAAI
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
MED
IF11.8
2023-10-015
OA
NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation
2021-11-2225
OA
Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors
2021-06-2350
OAAI
Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer
2019-12-2633
OAAI
Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy
2018-05-1859
OAAI